Nasdaq
QNCX
Quince Therapeutics, Inc.
- Health Care
- Listed 2019
- 1 day
- +2.3%
- 1 month
- +68.8%
- 1 year
- −91.1%
$29.54 · Mkt cap $30.0M
At the 6 Aug 2026 close
Nasdaq
Quince Therapeutics, Inc.
$29.54 · Mkt cap $30.0M
At the 6 Aug 2026 close
Quince Therapeutics, Inc. trades under the ticker QNCX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2019. Its market capitalisation is $30.0M. The last closing price was $29.54, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −91.1%, and +68.8% over the past month. Returns are price returns and exclude dividends.
This page exists because QNCX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.